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CObjectives: The National Health Insurance in Taiwan provides the en-
tire population with universal coverage and full freedom to access
health care, and thus results in accelerating medical utilization and
costs. A differential outpatient co-payment was introduced on July 15,
2005, to deter nonessential visits and encourage initial contact in pri-
mary care and a stepwise access to health care (referral system). A
previous study, however, showed a limited impact of this co-payment
policy on reducing medical utilization and improving the referral sys-
tem. This qualitative study aimed to explore Taiwanese patients’ deci-
sion-making process to access health care and how the cost issue im-
pacts patients’ access to health care and explore patients’ cost-saving
strategies. Methods: Hypertensive patients from different tiers of
medical facilities (community, regional hospitals, and medical centers)
in the Kao-Ping area of southern Taiwan were invited to participate in
focus groups from October 2008 to January 2009. Results: Of all, 40
participants were recruited for nine focus groups. The physicians’ rep-
utation, tiers of hospitals, and the convenience of transport and regis- O
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doi:10.1016/j.vhri.2012.03.010ration are the three major reasons why participants accessed different
edical facilities. Participants expressed that the current out-of-
ocket payment is affordable and not as important as other reasons for
heir choices. Continuous prescription was considered a cost-saving
trategy for patients visiting higher tiers of medical facilities. Most par-
icipants were not fully aware of current National Health Insurance
egulations such as co-payment, continuous prescriptions, and the re-
erral policy. Conclusions: The current out-of-pocket payment is af-
ordable for hypertensive patients receiving regular treatments, but it
ails to reduce the demand of health care. To establish a proper evalu-
tion of the co-payment policy, future study is suggested to consider
he views from health care providers and financially vulnerable pa-
ients.
eywords: accessibility, affordability, continuous prescription, co-pay-
ent, hypertension, out-of-pocket payment.
opyright © 2012, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Increasing health care expenditure is a worldwide trend [1]. The
growth of direct medical costs, and particularly the cost of pre-
scription medicines, is a major challenge to public expenditure
policies [2]. A variety of co-payment systems have been imple-
mented in many countries as a measure to constrain health care
expenditure by avoiding consumers’ moral hazard and reducing
the inappropriate use of health care services and nonessential
drug consumption. Prior studies have generally found that co-
payment can reduce both necessary and unnecessary medical
utilization [3–5]. Certain patient groups [6,7], such as nonex-
mpt patients on regular medication [8], the elderly [9,10], and
hose on low incomes [7], are especially sensitive to co-payment
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Published by Elsevier Inc.hanges, and this raises concerns that co-payment may cause
nintended outcomes in the treatments of some diseases [3–
,10,11].
Health care system in Taiwan
The National Health Insurance (NHI) system in Taiwan was estab-
lished in 1995 and is a government-run, single-payer scheme admin-
istered by the Bureau of National Health Insurance (BNHI). It provides
universal coverage to more than 99.64% of the population [12] for a
ariety of services, including inpatient care, outpatient care, labora-
ory tests, pharmaceuticals, dental services, traditional Chinese
edicine, day care for the mentally ill, and skilled nursing at home
13]. It is delivered by a combination of public and private sectors and
eimbursed by a fee-for-service under a “global budget system.”
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(physician clinics), secondary (regional hospitals, local commu-
nity hospitals), and tertiary care (medical centers) for providing
different levels of health care does exist in Taiwan, all levels also
provide outpatient services, and Taiwanese patients are free to
choose care providers and tiers of medical facilities. Therefore,
there is no gatekeeper system for outpatient visits [14] and there is
no established referral system among the tiers [15].
The NHI has improved accessibility to health care and provided
acceptable quality at an affordable cost, and so there is a high level
of satisfaction from the general public. With generous coverage
and patients’ freedom to access different tiers of medical facilities,
however, the NHI faced financial crisis and deficits after 3 years of
implementation. The costs of outpatient care, especially those
claims from higher tiers of medical facilities, have constituted the
majority of NHI expenditure [16]. As a result, the NHI began to
implement a co-payment charge, global budget programs, and in-
creasing premiums to control the rising costs.
Co-payment and cost-saving strategy
Currently, the out-of-pocket payment for outpatient visits is
mainly composed of the co-payment charge and the registration
fee. The registration fee is revenue for providers, and it usually
ranges from 50 to 250 Taiwan dollars subject to the provider’s
decision (1 Taiwan dollarUS $0.03 in October 2010). Because it is
regarded as an administration charge, the registration fee is not
covered by BNHI’s benefit scheme.
The current co-payment is based on a three-level charge (Table
1). To promote the referral system and decrease nonessential out-
patient visits, a “non-referral co-payment policy” was imple-
mented in July 2005. If the insured persons directly access outpa-
tient services in hospitals without referral, then they will have to
pay an extra of 60% of the normal co-payment charge in local
hospitals and 70% in regional hospitals and medical centers, al-
though there is no extra charge at clinics [16,17]. Some insured
people are exempt from the co-payment under the following con-
ditions: veterans, those on low incomes, people from remote
mountain areas and outlying islands, those suffering from major
illness and injury and women undergoing child delivery [13,18].
To reduce unnecessary outpatient visits and prescribing, the
BNHI has also implemented a multiple drug refills scheme for
chronic diseases, applying at each tier of medical facility. Patients
with stable chronic disease conditions can obtain continuous pre-
scriptions, which allow monthly refills up to 3 months at a time
without the need for further visits and drug co-payment. In addi-
tion, patients have total freedom to choose dispensing sites for
continuous prescriptions, which can be at community pharmacies
Table 1 – Outpatient visit co-payment and registration fee
Tiers of medical facilities Co-payment per v
Referral Non
Tertiary care
Medical centers 210
Secondary care
Regional hospitals 140
Local hospitals 50
Primary care
Clinics 50
Notes. The total out-of-pocket payment includes co-payment (co-paym
in Taiwan dollars (1 Taiwan dollarUS $0.03 in October 2010). The new
per-capita gross domestic product in Taiwan was US $16,372.31 in 20
To assist the international readership to interpret the potential impac
that would be understood, for example, percentage of average weeklwith no registration fee charge.Previous research on co-payment policy measure
Previous research has suggested that the increase in the nonrefer-
ral outpatient co-payment reduced the use of medical facilities but
failed to promote the referral system, and medical centers were
less influenced by the policy [19]. Theoretically, an increase in
out-of-pocket payments affects patients financially and conse-
quently their access to different tiers of medical facilities, and also
their attitude to using medicine [20,21]. Patients’ choices when
they access medical facilities, however, might be influenced by
wider socioeconomic perspectives and attitudes [22–26]. There-
fore, this study aimed to understand the decision-making process
of Taiwanese patients when they access health care and exam-
ined whether out-of-pocket payments will influence their deci-
sions and their perceptions of the referral system and the co-pay-
ment policy.
Methods
A qualitative approach was used because it is efficient to explore
complex behaviors, attitudes of key actors, and interactions be-
tween actors, organizations, and interventions [27]. To minimize
the influence of disease severity and include wider socioeconomic
groups, we conducted focus groups from October 2008 to January
2009 and recruited participants from outpatient clinics at different
tiers of medical facilities in the Kao-Ping area of southern Taiwan.
We also contacted the local community health promotion groups
for recruiting participants.
Adult hypertension outpatients who can speak either Manda-
rin or Taiwanese and voluntarily expressed interested in partici-
pating in the research were referred by their physicians at visits to
an on-site researcher for scheduling focus group. Hypertensive
patients were targeted for this study not only because the neces-
sity for long-term follow-up may incur higher accumulated out-
of-pocket payments but also because of the fact that obscure
symptoms for this chronic disease may incur more trade-off deci-
sions on treatments now to prevent potential complications in the
future.
All participants were informed about the processes of research
and assured of confidentiality and anonymity and gave their con-
sent to the study and audio-recording. The initial plan was to re-
cruit eight focus groups (two from each tier) or until main themes
were saturated. Each focus group lasted for about 30 to 45 minutes
and was facilitated by one researcher by using a predefined dis-
cussion guide with open-ended questions that allowed for new
concepts, perceptions, and views.
All focus groups were recorded, subsequently transcribed
iwan.
Registration fee
per visit
Co-payment for
drugs
rral
100–150 0–200
50–150 0–200
50–100 0–200
50–100 0–200
for visits and co-payment for prescription drugs) plus registration fee
atient co-payment scheme was implemented from July 15, 2005. The
e co-payment, the cost should be referred to in terms of a benchmark
me or some such measure.in Ta
isit
refe
360
240
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until the saturation of emerging themes [22–26,30] was
chieved and no new issues were identified. Discussions were
eld when there was a discrepancy between the two research-
rs, and it was resolved by reviewing the transcripts. To ensure
he accuracy of quotes, a forward and backward translation be-
ween Chinese and English was conducted. This study was ap-
roved by the Institutional Review Board at a medical center in
outhern Taiwan.
Results
Of all, we conducted nine focus group including 40 participants
from community (one group), regional hospital (four groups), and
medical center (four groups). There were insufficient volunteers
from local hospitals and physician clinics to participate in focus
group because of the difficulty in scheduling meeting time. Partic-
ipants vary in backgrounds, ages, hypertensive history (1 year to
10 years), and disease complications; most participants were fe-
males, and two were exempt from co-payments (Table 2). Emerg-
ing themes focus on factors that affect participants’ decisions
about accessing different tiers of medical facilities, further explo-
ration of issues beyond affordability, and participants’ perceptions
of issues around cost-saving strategies.
Decision making when accessing medical facilities
There were a variety of factors considered by participants when
accessing different medical facilities. Saturated opinions suggest
that the physician’s reputation and friendliness, the medical tier’s
reputation, and convenience are the three key considerations and
were repeatedly mentioned by participants. Most notably, those
participants visiting hospitals thought that the doctor’s reputation
was indicative of extensive knowledge and capability and that
more equipped medical facilities equated with high-quality equip-
ment and medicines for most participants.
“Oh, I definitely will see the doctor in which hospital; doctors are
the most important consideration.” [F2].
“I went to both hospitals (one regional hospital and one medical
center), because they belong to the same medical school, I always
choice to visit doctors there, and it’s also easy for me to travel.” [D4].
Table 2 – Characteristics of focus groups.
Group Number of
participants
Women:
Men
Age band
range (y)
Histor
hyperten
5 5–10
Medical
center
A 5 2:3 40–70 3 2
B 3 1:2 30–50 3 0
C 5 5:0 40–70 3 2
D 5 5:0 50–70 1 3
Regional
hospital
E 4 4:0 40–70 3 1
F 5 3:2 50–70 0 4
G 4 3:1 40–70 0 1
H 4 2:2 50–80 0 3
Physician
clinic
I 5 2:3 50–80 2 2“The doctors and nurses are friendly here; some doctors had bad
attitudes, so I don’t visit them anymore!” [A5].“You definitely get better examinations in bigger hospitals! How
can you get those equipments at physician clinics?” [C2].
Other factors such as the patients’ insight into the severity of
the diseases, normal visiting habits, information about doctors,
and medical facilities were also considered when accessing med-
ical facilities. Of all of them, out-of-pocket payments seem to be
the least important consideration and no participant ever proac-
tively mentioned “cost” issue as one of their considerations.
“The most important thing is the (therapeutic) ‘effect’! If the
doctor is excellent, well, cost is not important! You can’t just want
cheaper treatments! It’s useless if the doctor is not good.” [G2].
Participants valued the quality and efficiency of health care
services and trusted the quality of outpatient care provided at
hospitals. Some even thought hospitals provide better quality
medicines and guarantee quality treatment, and they worried that
the medicines prescribed and supplied at clinics might cause ad-
verse effects.
“Hay, it’s treatment effect that matters, not the cost. I come to
visit doctors for curing my diseases, so I will choice a trustworthy
doctor. Do you trust that local clinics will cure you and the medi-
cines (they prescribed) will not cause any allergy?” [D2].
Convenience of transportation and appointment-making is also
considered by participants because of time and cost saving; however,
because the number of outpatient visits at hospitals is under the
constraint of NHI’s global budget reimbursement policy, participants
generally felt that it is hard to make an outpatient appointment at
hospitals, especially in the higher tier facilities. Interestingly, some
participants visited hospitals more frequently—on a weekly basis—
when they could not make regular monthly visits, and consequently
incurred more out-of-pocket costs. In addition, if a favored physician
has more than one practice site, participants would then choose to
visit the site that is closer, less expensive, or easier to make appoint-
ment.
“Oh, my doctor asked me to come (visiting) here, it’s easier to
make an appointment, it’s nearby my house, and it’s the same
doctor anyway.” [E2].
Issues beyond affordability
Knowledge of cost disparities across tiers of medical facilities
Only a few participants knew current co-payment charges and
variances between tiers of medical facilities, especially the co-
payment for visiting hospitals. Some participants even misunder-
stood that out-of-pocket charges at private hospitals were higher
(y)
Participants’ monthly income band
(104 Taiwan dollars)
Participants
exempted from
co-payment
10 No 3 3–5 6–7 7 Unknown
0 2 1 0 1 0 1 0
0 1 0 1 0 1 0 0
0 2 2 0 0 0 1 0
1 2 1 0 1 0 1 1
0 1 0 2 0 0 1 0
1 2 1 0 0 1 1 0
3 2 0 2 0 0 0 0
1 2 1 1 0 0 0 0
1 2 0 2 1 0 0 1y of
sion
than at public hospitals, which are funded by government. Most
108 V A L U E I N H E A L T H R E G I O N A L I S S U E S 1 ( 2 0 1 2 ) 1 0 5 – 1 1 0participants were used to visiting fixed medical facilities and
lacked knowledge of current NHI regulations, and thus, they were
not aware of the cost disparities among different tiers of medical
facilities.
Out-of-pocket payment and medical accessibility
After being given full information about the differential between
co-payments across different medical tiers by the group facilita-
tor, participants who usually visit physician clinics regarded their
out-of-pocket payment as cheap, and most participants who did
not visit medical centers thought out-of-pocket payments at med-
ical centers were expensive. Despite being expensive, some par-
ticipants visiting regional hospitals and medical centers thought
the out-of pocket payments they paid were still acceptable. All
participants thought their current out-of-pocket payments were
affordable.
Insight into the disease and quality of drugs
Surprisingly, participants generally believed that hypertension is
a serious disease, and so essentially needs long-term treatment at
“higher tier” medical facilities, which were regarded as an assur-
ance of quality medical care and equipment.
“Generally, I come here (medical center) for some trouble
issues, such as this (hypertension) chronic disease! If I have a
cold or bad stomach, I will go to clinics, where the drug quality
is worse.” [D3].
Interestingly, some participants visiting at higher tiers of med-
ical facilities thought the “quality” of drug is important and be-
lieved that “the higher the tier of medical facilities, the better the
quality of the drug” and “the higher the drug cost, the better the
drug quality.” Some participants preferred brand name drugs to
generic drugs, because they had the impression that they could get
brand name drugs easier at higher tiers of medical facilities,
whereas they could get only generic drugs at physician clinics
according to previous experiences, and thus they distrusted the
quality of drugs supplied at physician clinics and community
pharmacies.
“You know, at the medical center, the doctor always prescribed me
branded drugs, but the clinics can only give me generic drugs; while
the pharmacies, well, you have to choice the right one.” [G1]
Perception of cost-saving strategies
Continuous prescriptions
Continuous prescription is a cost-saving strategy that a physician
might use to help nonexempted patients’ out-of-pocket burden.
Some participants thought that only those doctors who served at
higher tiers of medical facilities could prescribe continuous pre-
scriptions for up to 3 months, while at physician clinics, they could
issue only 3- to 7-day prescriptions. Therefore, they thought visit-
ing hospitals is better value than going to clinics in the long run.
“Well, at clinic, it’s 200 dollars for three-day drugs. But hyper-
tension, hay, it’s a chronic disease, how can you possibly go to
clinics every two or three days? Well, go to medical center, doctor
will give (prescribe) me two- or three-month drugs, I don’t have to
come very often. Although every visit is more expensive, overall,
thinking of the cost and time-saving, it’s still better value.” [C2].
In addition, some participants with multiple comorbidities
mentioned that doctors at hospitals could prescribe multiple med-
icines to cover all their conditions, which resulted in better value.
Overall, the current out-of-pocket payment is considered afford-
able, especially when doctors prescribed continuous prescriptions
to save patient’s co-payment charge.
Having continuous prescriptions dispensed at community
pharmacies is one cost-saving strategy to avoid the co-payment of
visits suggested by participants. Some participants, however, werenot aware that the service was available at pharmacies and that
they did not have to pay the co-payment and registration fee. After
being given full information on the dispensing service of continu-
ous prescriptions at community pharmacies, a few participants
said they would consider using this service for cost-saving. Most
participants, however, still preferred to have their continuous pre-
scriptions dispensed at the site they visited and were reluctant to
change current dispensing sites because they were worried that
pharmacies might supply different drugs from those available at
medical facilities, and some mistrusted the quality of drugs sup-
plied at pharmacies.
Perceptions of referral policy
The referral policy is one of NHI’s strategies to discourage patients
with minor illnesses from visiting higher tier facilities. Most par-
ticipants, however, had never heard of the referral policy and only
a few had a vague knowledge of the policy. Even after being given
full information about the purpose and process of referral, partic-
ipants disliked the idea of being transferred from lower to higher
tiers of medical facilities because it was inconvenient and unat-
tractive in terms of cost; some worried that time wasted on refer-
ral would delay treatment. In addition, participants thought that
because the referral decision is controlled by physicians it is irrel-
evant to patients, and the co-payment policy will not encourage
patients to use the referral system.
“Hmm, it is not for me, it’s waste of time and the prices are not
much different (between referral and direct access). I would con-
sider (going referral) if that’s free, is it any difference for 150 dol-
lars?” [G2].
“I don’t think it (referral) will happen frequently, unless diseases
are very severe, otherwise, doctors will lose their income.” [I8].
Financial discussions with doctors
The participants visiting different tiers of medical facilities did not
feel that their own health care was a financial burden, but some
concerns were raised that the burden of medical payments might
accrue for their relatives, people with low income, the elderly, or
patients with multiple diseases, and thus lead to social inequity
issues. They felt, however, that financial issues should not be dis-
cussed between doctors and patients. Even if they had financial
issues, participants did not wish to discuss these with doctors
because they felt it was shameful and unhelpful.
“No way! Discuss (financial issues) with doctors? No, that’s a
personal issue! Doctors are only responsible to treat patients, why
should they bother about it? Why should I tell them? It’s embar-
rassing! Even if I have any (financial) difficulty (in paying), I would
deal with it myself.” [E2].
Discussion
Main findings
This study was conducted on the basis of a previous quantita-
tive claim-based data analysis [19]. We used a qualitative ap-
proach to explore the Taiwanese hypertensive patients’ deci-
sion-making process to access health care, to examine the
fundamental hypothesis of the co-payment policy, that is,
whether cost is really an issue to patients in Taiwan, and why
the current co-payment policy failed to reach its goal in terms of
improving the referral system.
We found that the physicians’ reputation, the medical tiers’
reputation, and convenience are the major considerations when
participants make decisions about accessing different medical fa-
cilities. These findings were consistent with one domestic survey
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prescription charge [24,25]. Of all the various personal consider-
tions, out-of-pocket cost was not perceived as an important fac-
or in participants’ choices. The finding suggests that the current
o-payment charge may be too low to have an impact on demands
or health care and a higher co-payment charge is possibly re-
uired.
Strength and limitations
The qualitative technique is considered an appropriate approach
to study cognitive and behavioral issues; in this study, it provides
a better understanding of the nature of the decision-making pro-
cess and thus adds to insights into the impact of a policy in a
number of contexts. For the 40 hypertensive patients who partic-
ipated in the study, we carefully modulated the focus groups and
kept the groups dynamic to deeply explore participants’ percep-
tions, and the emerging themes all reached the saturation of opin-
ions. There are, however, several technical concerns that may in-
fluence the validity of this study.
Ideally, to explore the relationship between the out-of-pocket
cost and medical demands, views from patients with affordability
problems should be included. In reality, it is difficult to identify
and recruit patients who are unable to access health care. Alter-
natively, we tried to recruit participants from a wide range of med-
ical facilities. It was, however, also difficult to recruit participants
from physician clinics because patients who accessed clinics were
likely to expect short visits and unwilling to spare time on sched-
uling and participate in the study. Although we tried to contact the
health care promotion groups to recruit participates from the local
community, the majority of enrolled participants were still ac-
cepting health care in higher tier medical facilities, and hence they
may have no financial problems or there are other factors that
outweigh the cost issue in participants’ choices.
The participants were mainly recruited from the Kao-Ping area,
which is one of the six regions administered by the BNHI, includ-
ing the second largest city, two counties, and a remote island in
Taiwan. The population is generally understudied compared with
the population in the capital city, Taipei, yet they may better rep-
resent the general population in Taiwan because of its unique
socioeconomic diversity [32]. According to our previous qualitative
tudy [19], the clinical practice and medical utilization patterns in
he Kao-Ping branch were found similar to those in other regions
n Taiwan. Nevertheless, we do acknowledge that the results of
his study with limited number of participants are not well repre-
entative of the entire population in Taiwan.
Implications
Factors influencing the decision making
Because Taiwanese people have total freedom to access different
medical services, the tier of medical facility has represented the qual-
ity of medical care, equipment, and drugs. Without any financial
problems, hypertensive patients preferred to access higher tiers of
medical facilities not only because of their faith in the quality of care
but also because of their insight into the severity of the disease.
Participants thought that hypertension is a serious disease that
needs advanced treatment at higher tier facilities rather than reg-
ular follow-ups at lower tier facilities. Particularly those partici-
pants with multiple diseases tend to continue using higher tier
medical facilities because they can visit different specialists at the
same hospital and drug costs can be reduced via continuous pre-
scriptions. This suggested that there is a need to improve a hyper-
tensive patient’s disease-related and self-care knowledge.Policy knowledge gap
A previous survey conducted at a local medical center in Taiwan
found that the public was not generally aware of the co-payment
policy even 18 months after its implementation [33]. In our study,
we found that almost all participants accepted medical charges
passively even though they were not entirely satisfied with the
costs, and many did not know the differential costs between hos-
pitals and clinics. Although lack of knowledge about NHI regula-
tions persists, after the provision of co-payment information,
most of our participants accepted the cost difference and only a
few participants considered changing medical facilities.
A lack of knowledge also exists on the nonreferral co-pay-
ment policy, and so the NHI needs to improve policy dissemi-
nation and awareness among the general public. Even after be-
ing given full information, however, participants rejected the
idea of transferring from lower to higher tiers, not only because
of the lack of price incentive but also because the process was
inconvenient. With widespread and accessible medical facili-
ties, Taiwanese people usually enjoy the convenience of easy
access to health care (especially in metropolitan areas) and that
jeopardizes the implementation of the referral system. Wasted
time and complicated procedures were also found to be the
main issues in a survey on satisfaction with the co-payment
policy [33]. In addition, physicians were thought to be the key
decision makers when it came to transferring and hence partic-
ipants felt they had no choice.
Prescriptions and cost-saving
By enquiring at outpatients departments of hospitals, we can
identify continuous prescription as an important strategy for pa-
tients to cope with the higher out-of-pocket charge. As is consis-
tent with a previous questionnaire survey on continuous prescrip-
tions [34], however, we also found that only a few participants
understood that continuous prescriptions can be dispensed at
pharmacies free of charge [35]. After being given full information,
some participants were persuaded that having their continuous
prescriptions dispensed at pharmacies will save them money in
the future.
Interestingly, the brand of drugs also influences hypertensive
patients’ choice of dispensing sites for their continuous prescrip-
tions. We found that participants at higher tiers were sensitive to
the appearance or brand of drugs. Some participants visiting
higher tier medical facilities had their prescriptions dispensed on
site rather than in clinics or pharmacies. They did this to get better
quality drugs because they thought that clinics or pharmacies
tend to provide generic drugs.
Nevertheless, to maintain drug procurement profit, hospital
staff encouraged participants to get their continuous prescriptions
refilled at hospitals even though a few were not happy with the
hospital registration charge. Participants’ misconception that clin-
ics are not able to prescribe continuous prescriptions is one reason
why participants go to higher tiers medical facilities. To avoid un-
necessary use of medical resources, we suggest that the NHI
should encourage general practitioners to prescribe continuous
prescriptions and encourage patients to have their continuous
prescriptions dispensed at pharmacies.
Increasing co-payment
The results of our research found that the current co-payment
charge is insufficient to have an influence on medical utilization of
hypertensive patients under routine treatments. Even though the
current out-of-pocket payment is considered affordable, we found
a few participants at higher tiers who thought that the out-of-
pocket cost is expensive, although other considerations outweigh
cost concerns when they are choosing medical facilities. More-
over, the adverse impact of the co-payment policy on necessary
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also a concern of some participants. Similar inequity issues have
also been raised by previous quantitative studies examining NHI
policy impact [19], in particular, outpatient visits, which are cur-
rently limited by NHI’s global budget policy, and so patients who
are not able to book an appointment will need to pay the total cost
out of their own pockets.
Conclusions
In summary, we found that the current co-payment charge is still
affordable for hypertensive patients receiving regular treatments,
and their choices about accessing different medical facilities depend
on the physicians’ reputation, the medical tiers’ reputation, and con-
venience. Physicians play a predominant role in patients’ medical
use, but patients neither involve them when deciding on their treat-
ment options nor discuss affordability issues with their physicians.
Continuous prescription is an important cost-saving strategy for hy-
pertensive patients visiting higher tiers of medical facilities. Patients
still have a lack of knowledge about current NHI regulations, includ-
ing co-payment, continuous prescriptions, and the referral policy.
To properly implement the co-payment policy and the referral
system, the BNHI needs to put more effort into improving patients’
awareness of health care regulations and current policy. To estab-
lish a better evaluation of the co-payment policy, future studies
should elicit the views of physicians and explore perspectives
from vulnerable patients, such as patients from remote areas,
with different diseases, or with financial problems.
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